Viewing Study NCT05303532


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-01-01 @ 3:57 AM
Study NCT ID: NCT05303532
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-11-26
First Post: 2022-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module